According to Vitrolife AB's latest financial reports the company's current revenue (TTM ) is A$0.55 Billion. In 2023 the company made a revenue of A$0.48 Billion an increase over the revenue in the year 2022 that were of A$0.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | A$0.51 B | 4.26% |
2023 | A$0.48 B | 5.22% |
2022 | A$0.46 B | 76.19% |
2021 | A$0.26 B | 46.91% |
2020 | A$0.17 B | -19.92% |
2019 | A$0.22 B | 20.77% |
2018 | A$0.18 B | 16.61% |
2017 | A$0.15 B | 15.11% |
2016 | A$0.13 B | 17.16% |
2015 | A$0.11 B | 33.34% |
2014 | A$88.58 M | 13.69% |
2013 | A$77.91 M | 48.69% |
2012 | A$52.4 M | 6.07% |
2011 | A$49.4 M | 19.54% |
2010 | A$41.32 M |